A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer. [PDF]
Miura Y +9 more
europepmc +1 more source
Impact of perineural tumor spread in head and neck adenoid cystic carcinoma for carbon-ion radiotherapy. [PDF]
Musha A +11 more
europepmc +1 more source
Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion radiotherapy boost for high-grade gliomas: a retrospective study. [PDF]
Li X +7 more
europepmc +1 more source
Clinical indications and future directions of carbon-ion radiotherapy: a narrative review. [PDF]
Choi SH +8 more
europepmc +1 more source
Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer. [PDF]
Sishc BJ +13 more
europepmc +1 more source
An unusual case of oral mucosal melanoma successfully treated by carbon-ion radiotherapy. [PDF]
Ikawa H, Koto M.
europepmc +1 more source
Fatal Duodenal Ulcer Hemorrhage in a Post-Operative Patient of Proximal Femur Fracture Undergoing Carbon Ion Radiotherapy for Locally Advanced Pancreatic Carcinoma: A Case Report. [PDF]
Iida H +4 more
europepmc +1 more source
Size-Sorted Superheated Nanodroplets for Dosimetry and Range Verification of Carbon-Ion Radiotherapy. [PDF]
Toumia Y +7 more
europepmc +1 more source
Related searches:
Clinical Indications for Carbon Ion Radiotherapy
Clinical Oncology, 2018Compared with photon and proton therapy, carbon ion radiotherapy (CIRT) offers potentially superior dose distributions, which may permit dose escalation with the potential for improved sparing of adjacent normal tissues. CIRT has increased biological effectiveness leading to increased tumour killing compared with other radiation modalities.
Mohamad, O., Yamada, S., Durante, M.
openaire +3 more sources

